Adbry® (tralokinumab-ldrm)
for Atopic Dermatitis – Eczema

Adbry (tralokinumab-ldrm) is an interleukin-13 (IL-13) inhibitor used to treat moderate-to-severe atopic dermatitis (eczema) in adults and children 12 years and older who do not respond well to topical treatments. Adbry works by targeting IL-13, a key protein involved in skin inflammation, helping to reduce symptoms of eczema.

Heart
Medication Guide Icon Medication Guide
TV Commercial Icon TV Commercial
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Atopic Dermatitis - Eczema